Mango L., et al. Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Human Experimental Toxicology1996; 15: (Suppl 1) 520-535.
2.
OECD Draft Guidance Document (June 1996) Neurotoxicity Strategy and Methods.
3.
OECD Guideline 418 Delayed neurotoxicity of organphosphorus Substances following acute exposure (July 1995).
4.
OECD Guideline 419 Delayed neurotoxicity of organophosphorus Substances: 28 day repeated dose study (July 1995).
5.
US EPA 1991; Guidelines TSCA/FIFRA.
6.
US FDA Redbook II guidelines, 1993.
7.
Rowles TK, Song X., Ehrich M.Identification of endpoints affected by exposure of human neuroblastoma cells to neuroticants at concentrations below those that affect cell viability . In Vitro Toxicology1995; 8: 3-13.
8.
Atterwill CK, et al. Alternative methods and their application in neurotoxicity testing. In: Animals & Alternatives in Toxicology, (Ed) Balls M, Bridges J and Southee J. Macmillan Poen1991; 121-152.
9.
Veronesi B.In vitro screening batteries for neurotoxicants. Neurotoxicology1992; 13: 185-196.
10.
Cookson M., Pentreath V.Alterations in the glial fibrillary acidic protein content of primary astrocyte cultures for evaluation of glial cell toxicity. Toxicol In Vitro1994; 8: 351 -359.
11.
Atterwill CKBrain reaggregate cultures in neurotoxicological investigations: studies with cholinergic neurotoxins. ATLA1989; 16: 221- 230.
12.
Atterwill CK , et al. In vitro neurotoxicity testing. ECVAM Workshop Report No 3, ATLA1994; 22: 250 -362.
13.
Williams SP, et al. An in vitro neurotoxicity testing scheme: evaluation of cytotoxicity determinations in neural and non-neural cells. In Vitro Toxicology, 1996; 9: 83 -92.
14.
Veronesi B. , Ehrich M.Using neuroblastoma cell lines to examine OP Neurotoxicity. In Vitro Toxicology1993 ; 6: 57 -65.
15.
Honegger P., Schilter B.Serum-free aggregate cultures of fetal rat brain and liver cells: methodology and some practical applications in neurotoxicology. In 'The Brain in Bits and Pieces', (Ed) G Zbinden.MTCVerlag, Switzerland, 1992. 51 -72.
16.
Brunink A.Serum-free monolayer cultures of fetal chick brain and retina: immunoassays of developmental markers, mathematical data analysis and establishment of optimal culture conditions. In 'The Brain in Bits and Pieces' (Ed) G Zbinden.MTGVerlag, Switzerland, 1992. 23 -47.
17.
Bystry RS, Fox RM, Atterwill CKDevelopment of a novel in vitro blood brain barrier using whole rat brain reaggregates and rat-brain derived endothelial cells. Human & Exp Toxicology1995; 14: 737 - 773.
18.
Dohouck M-P. , et al. Drug transfer across the blood-brain-barrier: correlation between in vitro and in vivo models. J Neurochem1992; 58: 1790-1797.
19.
O'Callaghan JPAssessment of neurotoxicity; use of glial fibrillary acidic protein as a biomarkerBiomed Environ Sci1991; 4: 197-206.
20.
Purcell W., Atterwill CKMast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochemical Research1995 ; 20: 521- 532.
